CVS Caremark decides not to cut payments for 340B Providers

CVS Caremark reversed a plan to change reimbursements for pharmacies that contract with 340B hospitals, according to a report from America’s Essential Hospitals. The news was sent in a confidential notice to hospitals participating in the 340B Drug Pricing Program. The initial plan, said the report, was to potentially deny rebates provided through the pharmacy benefit manager (PBM) and had also reserved the right to “apply unique terms and conditions” to 340B providers’ retail networks. America’s Essential Hospitals reported that the changes, scheduled to take effect April 1, would have resulted in substantial reimbursement cuts to 340B hospitals.

Visit America’s Essential Hospitals for the article.